{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:57:55Z","timestamp":1793674675502,"version":"4.5.1"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>Accumulating basic science data, early clinical findings and various feasibility considerations have provided rationales for administering ketamine as a proposed rescue medication for midazolam-resistant status epilepticus (SE) in the logistically challenging prehospital environment. This report details the multiyear experience of paramedics managing midazolam-resistant SE following the introduction of a ketamine-rescue protocol.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>A 7-year, population-based, observational study was conducted to evaluate outcomes of patients treated with IV, intraosseous, intramuscular, or intranasal ketamine for SE despite sufficient midazolam dosings. Tracked outcomes included: 1) rapid\/sustained termination of clinical seizures in adults while under paramedics\u2019 care; 2) corresponding evaluations in children\/adolescents; 3) any concerning observations regarding need for assisted ventilation, intubation, or other active interventions post-ketamine; and 4) any identifiable associations between outcomes and circumstances, demographics, or medical history.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>Emergency response 9-1-1 system serving a large, diverse U.S. county (jurisdictional population, 961,000\/1,769 sq miles).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Those receiving ketamine from paramedics for persistent seizures.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>Adults and adolescents: 100\u2009mg ketamine IV\/intraosseous\/intramuscular\/intranasal; children: 1\u2009mg\/kg intramuscular\/intranasal.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>Among 81 total cases, 57 involved adults (18\u201386 yr old) receiving the SE-midazolam + ketamine protocol. Ketamine rapidly terminated convulsions in 56 (98.2%) without recurrence during prehospital and hospital arrival phases. For approved reasons, paramedics administered ketamine directly (no midazolam) in eight adults and one child, terminating convulsions in every case. Among 15 childhood\/adolescent cases treated per protocol, ketamine rapidly terminated SE activity in 11, but only mitigated it in four, including two retrospectively judged to involve nonseizure activity and two involving intranasal administration. Among all 81 ketamine-treated cases, there were no identifiable clinically significant complications attributable to ketamine, particularly the need for any additional active interventions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Ketamine appeared to be consistently effective in treating adults with ongoing out-of-hospital seizures that were resistant to sufficient dosings of midazolam. Similar results were observed in children\/adolescents.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000001186","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T21:00:12Z","timestamp":1733518812000},"page":"e1186","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Effectiveness of Ketamine As a Rescue Drug for Patients Experiencing Benzodiazepine-Resistant Status Epilepticus in the Prehospital Setting"],"prefix":"10.1097","volume":"6","author":[{"given":"Kenneth A.","family":"Scheppke","sequence":"first","affiliation":[{"name":"Palm Beach County Fire Rescue, Palm Beach County, West Palm Beach, FL."},{"name":"Florida Department of Health, Tallahassee, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7765-6567","authenticated-orcid":false,"given":"Paul E.","family":"Pepe","sequence":"additional","affiliation":[{"name":"Palm Beach County Fire Rescue, Palm Beach County, West Palm Beach, FL."},{"name":"Department of Management, Policy and Community Health, University of Texas Health Sciences Center, School of Public Health, Houston, TX."},{"name":"Coral Springs\/Parkland Fire Department, City of Coral Springs, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian A.","family":"Garay","sequence":"additional","affiliation":[{"name":"Palm Beach County Fire Rescue, Palm Beach County, West Palm Beach, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles W.","family":"Coyle","sequence":"additional","affiliation":[{"name":"Palm Beach County Fire Rescue, Palm Beach County, West Palm Beach, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Antevy","sequence":"additional","affiliation":[{"name":"Palm Beach County Fire Rescue, Palm Beach County, West Palm Beach, FL."},{"name":"Coral Springs\/Parkland Fire Department, City of Coral Springs, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Perlmutter","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Hennepin County Medical Center, Minneapolis, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric K.","family":"Scheppke","sequence":"additional","affiliation":[{"name":"Edward Via College of Osteopathic Medicine, Auburn, AL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remle P.","family":"Crowe","sequence":"additional","affiliation":[{"name":"Department of Clinical and Operational Research, ESO, Austin, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"key":"R1-20241206","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1528-1157.1999.tb02000.x","article-title":"It\u2019s time to revise the definition of status epilepticus.","volume":"40","author":"Lowenstein","year":"1999","journal-title":"Epilepsia"},{"key":"R2-20241206","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus\u2014report of the ILAE task force on classification of status epilepticus.","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"R3-20241206","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/epi.14602","article-title":"High long-term mortality after incident status epilepticus in adults: Results from a population-based study.","volume":"60","author":"Rodin","year":"2019","journal-title":"Epilepsia"},{"key":"R4-20241206","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1097\/CCM.0b013e3181f859a6","article-title":"Functional outcome after convulsive status epilepticus.","volume":"38","author":"Legriel","year":"2010","journal-title":"Crit Care Med"},{"key":"R5-20241206","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-94-017-8914-1_9","article-title":"When and how do seizures kill neurons, and is cell death relevant to epileptogenesis?","volume":"813","author":"Dingledine","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"R6-20241206","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: Treatment of convulsive status epilepticus in children and adults: Report of the Guideline Committee of the American Epilepsy Society.","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"key":"R7-20241206","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus.","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N Engl J Med"},{"key":"R8-20241206","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/epi.12037","article-title":"Possible alterations in GABA-A receptor signaling that underlie benzodiazepine-resistant seizures.","volume":"53","author":"Deeb","year":"2012","journal-title":"Epilepsia"},{"key":"R9-20241206","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1152\/jn.01180.2007","article-title":"Alterations of GABA-A-receptor function and allosteric modulation during development of status epilepticus.","volume":"99","author":"Feng","year":"2008","journal-title":"J Neurophysiol"},{"key":"R10-20241206","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.seizure.2015.05.010","article-title":"Ketamine for the treatment of refractory status epilepticus.","volume":"30","author":"Fang","year":"2015","journal-title":"Seizure"},{"key":"R11-20241206","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s12028-013-9939-6","article-title":"NMDA antagonists for refractory seizures.","volume":"20","author":"Zeiler","year":"2014","journal-title":"Neurocrit Care"},{"key":"R12-20241206","first-page":"7","article-title":"The glutamate receptor ion channels.","volume":"51","author":"Dingledine","year":"1999","journal-title":"Pharmacol Rev"},{"key":"R13-20241206","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(99)00238-4","article-title":"N-methyl-D-aspartate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat.","volume":"265","author":"Mazarati","year":"1999","journal-title":"Neurosci Lett"},{"key":"R14-20241206","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s40263-018-0569-6","article-title":"Ketamine for refractory status epilepticus: A systematic review.","volume":"32","author":"Rosati","year":"2018","journal-title":"CNS Drugs"},{"key":"R15-20241206","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s13311-018-0640-5","article-title":"Treatment of refractory and super-refractory status epilepticus.","volume":"15","author":"Rai","year":"2018","journal-title":"Neurotherapeutics"},{"key":"R16-20241206","doi-asserted-by":"crossref","first-page":"106367","DOI":"10.1016\/j.yebeh.2019.06.011","article-title":"Early polytherapy for benzodiazepine-refractory status epilepticus.","volume":"101","author":"Niquet","year":"2019","journal-title":"Epilepsy Behav"},{"key":"R17-20241206","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.seizure.2017.02.015","article-title":"Challenges in the treatment of convulsive status epilepticus.","volume":"47","author":"Zaccara","year":"2017","journal-title":"Seizure"},{"key":"R18-20241206","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41397-019-0120-2","article-title":"Ketamine in seizure management and future pharmacogenomic considerations.","volume":"20","author":"Borsato","year":"2020","journal-title":"Pharmacogenomics J"},{"key":"R19-20241206","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/WNF.0b013e3181d1e3cd","article-title":"Terminating prolonged refractory status epilepticus using ketamine.","volume":"33","author":"Hsieh","year":"2010","journal-title":"Clin Neuropharmacol"},{"key":"R20-20241206","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.pediatrneurol.2014.03.006","article-title":"Use of ketamine in a new-born with refractory status epilepticus: A case report.","volume":"51","author":"Tarocco","year":"2014","journal-title":"Pediatr Neurol"},{"key":"R21-20241206","doi-asserted-by":"crossref","first-page":"1189478","DOI":"10.3389\/fped.2023.1189478","article-title":"Efficacy and safety of ketamine for neonatal refractory status epilepticus: Case report and systematic review.","volume":"11","author":"Pin","year":"2023","journal-title":"Front Pediatr"},{"key":"R22-20241206","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.eplepsyres.2013.01.007","article-title":"Ketamine use in the treatment of refractory status epilepticus.","volume":"105","author":"Synowiec","year":"2013","journal-title":"Epilepsy Res"},{"key":"R23-20241206","doi-asserted-by":"crossref","first-page":"e2286","DOI":"10.1212\/WNL.0000000000010611","article-title":"Ketamine to treat super-refractory status epilepticus.","volume":"95","author":"Alkhachroum","year":"2020","journal-title":"Neurology"},{"key":"R24-20241206","doi-asserted-by":"crossref","first-page":"e1227","DOI":"10.1212\/WNL.0000000000200889","article-title":"Ketamine for management of neonatal and pediatric refractory status epilepticus.","volume":"99","author":"Jacobwitz","year":"2022","journal-title":"Neurology"},{"key":"R25-20241206","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s40263-016-0371-2","article-title":"(S)-Ketamine in refractory and super-refractory status epilepticus: A retrospective study.","volume":"30","author":"Ho\u0308fler","year":"2016","journal-title":"CNS Drugs"},{"key":"R26-20241206","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12028-022-01578-0","article-title":"Factors associated with refractory status epilepticus termination following ketamine initiation: A multivariable analysis model.","volume":"38","author":"Srinivas","year":"2023","journal-title":"Neurocrit Care"},{"key":"R27-20241206","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1080\/10903127.2023.2221967","article-title":"Prehospital treatment of benzodiazepine-resistant pediatric status epilepticus with parenteral ketamine: A case series.","volume":"27","author":"Perlmutter","year":"2023","journal-title":"Prehosp Emerg Care"},{"key":"R28-20241206","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.annemergmed.2021.02.020","article-title":"Out-of-hospital ketamine: Indications for use, patient outcomes, and associated mortality.","volume":"78","author":"Fernandez","year":"2021","journal-title":"Ann Emerg Med"},{"key":"R29-20241206","doi-asserted-by":"crossref","first-page":"736","DOI":"10.5811\/westjem.2014.9.23229","article-title":"Prehospital use of IM ketamine for sedation of violent and agitated patients.","volume":"15","author":"Scheppke","year":"2014","journal-title":"West J Emerg Med"},{"key":"R30-20241206","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/epi.14480","article-title":"Intravenous ketamine in status epilepticus.","volume":"59","author":"H\u00f6fler","year":"2018","journal-title":"Epilepsia"},{"key":"R31-20241206","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/epi.16825","article-title":"Patterns of benzodiazepine underdosing in the established status epilepticus treatment trial.","volume":"62","author":"Sathe","year":"2021","journal-title":"Epilepsia"},{"key":"R32-20241206","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0140-6736(20)30611-5","article-title":"Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): A double-blind, responsive-adaptive, randomised controlled trial.","volume":"395","author":"Chamberlain","year":"2020","journal-title":"Lancet"},{"key":"R33-20241206","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/jpcc.jpcc_52_22","article-title":"Comparison of levetiracetam as second-line drug with fosphenytoin in convulsive status epilepticus among children: A single center, open-label randomized controlled trial.","volume":"10","author":"Anupama","year":"2023","journal-title":"J Pediatr Crit Care"},{"key":"R34-20241206","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1528-1157.1995.tb00979.x","article-title":"Neuroprotective effect of ketamine administered after status epilepticus onset.","volume":"36","author":"Fujikawa","year":"1995","journal-title":"Epilepsia"},{"key":"R35-20241206","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ajem.2021.03.074","article-title":"Characterization of ketamine usage in a large tertiary-care emergency department.","volume":"47","author":"McKinley","year":"2021","journal-title":"Am J Emerg Med"},{"key":"R36-20241206","doi-asserted-by":"crossref","first-page":"272","DOI":"10.5811\/westjem.2019.10.43067","article-title":"Ketamine safety and use in the emergency department for pain and agitation\/delirium: A health system experience.","volume":"21","author":"Mo","year":"2020","journal-title":"West J Emerg Med"},{"key":"R37-20241206","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.amj.2023.09.011","article-title":"Ketamine efficacy for management of status epilepticus: Considerations for prehospital clinicians.","volume":"43","author":"Williams","year":"2024","journal-title":"Air Med J"},{"key":"R38-20241206","article-title":"Palm Beach County Florida Population Estimates.","year":"2022"},{"key":"R39-20241206","first-page":"560","article-title":"Status epilepticus and the use of continuous EEG monitoring in the intensive care unit.","volume":"18","author":"Bleck","year":"2012","journal-title":"Continuum (Minneap Minn)"},{"key":"R40-20241206","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/anae.15606","article-title":"Management of status epilepticus: A narrative review.","volume":"77","author":"Migdady","year":"2022","journal-title":"Anaesthesia"},{"key":"R41-20241206","doi-asserted-by":"crossref","first-page":"e677","DOI":"10.1212\/CPJ.0000000000000961","article-title":"Utility of routine EEG in emergency department and in-patient service.","volume":"11","author":"Rodriguez-Quintana","year":"2021","journal-title":"Neurol Clin Pract"},{"key":"R42-20241206","doi-asserted-by":"crossref","first-page":"113379","DOI":"10.1016\/j.jpeds.2023.02.023","article-title":"Prehospital seizure management in children: An evaluation of a nationally representative sample.","volume":"257","author":"Ramgopal","year":"2023","journal-title":"J Pediatr"},{"key":"R43-20241206","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/epi.17940","article-title":"Association of midazolam route of administration and need for recurrent dosing among children with seizures cared for by emergency medical services.","volume":"65","author":"Ramgopal","year":"2024","journal-title":"Epilepsia"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001186","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T21:00:26Z","timestamp":1733518826000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000001186","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]}}}